Profile
Michael Wittekind worked as an Executive Director-Research at Amgen, Inc. from 2003 to 2007, an Associate Director at Bristol-Myers Squibb Pharmaceutical Research Institute, and a Chief Scientific Officer & Senior VP-Research at ContraFect Corp.
from 2014 to 2016.
He also worked as a Director-Process Development at Phylos, Inc. Dr. Wittekind holds a doctorate degree from the University of Wisconsin and a graduate degree from the University of Washington.
Former positions of Michael Wittekind
| Companies | Position | End |
|---|---|---|
| CONTRAFECT CORPORATION | Chief Tech/Sci/R&D Officer | 2016-09-30 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2007-10-31 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | - |
Phylos, Inc.
 Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Training of Michael Wittekind
| University of Wisconsin | Doctorate Degree |
| University of Washington | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute |
- Stock Market
- Insiders
- Michael Wittekind
